Eyepoint Pharmaceuticals, Inc.
Records under this name other than the patents Eyepoint Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.
Back to Eyepoint Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,926,367 | ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF Formerly held In force · High confidence | In force | High confidence | |
| US 11,814,425 | ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,524,235 | Method for Treating Coronary Artery Disease Using Antibody Binding Human Protein Tyrosine Phosphatase Beta(HPTPbeta) Formerly held In force · High confidence | In force | High confidence | |
| US 8,871,241 | Injectable sustained release delivery devices Formerly held In force · High confidence | In force | High confidence | |
| US 7,998,108 | Injector Apparatus and Method of Use Formerly held In force · High confidence | In force | High confidence | |
| US 8,815,284 | Bioerodible Sustained Release Drug Delivery Systems Formerly held In force · High confidence | In force | High confidence | |
| US 7,973,142 | Antibodies That Bind Human Protein Tyrosine Phosphatase Beta (HPTPBETA) Formerly held In force · High confidence | In force | High confidence | |
| US 8,569,348 | Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells Formerly held In force · High confidence | In force | High confidence | |
| US 8,883,832 | Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells Formerly held In force · High confidence | In force | High confidence | |
| US 9,174,950 | Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells Formerly held In force · High confidence | In force | High confidence |